Although SB203580 is known as an inhibitor of p38 MAP kinase, some breast cancer studies using MDA-MB-231 cells have reported that the p38 MAP kinase pathway appears to be a major component of Smad-independent signaling by TGF-β [33, 34]. This evidence concerns the gene TGFB1 and breast cancer.